ebomi
Colour theme
Sign in
Insider · CIK 0001495110

Braunstein Douglas L

CIK 0001495110 Name as filed on the most recent filing

Filed as Braunstein Douglas L (31)

62 transaction lines · from 31 filings · filed 2017-08-11 to 2024-02-21 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

7 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-02-21 S, Open-market sale Cantaloupe, Inc.CTLP 570,667, disposed Open Form 4 filing 0001104659-24-026192
2022-05-25 P, Open-market purchase Cantaloupe, Inc.CTLP 86,650, acquired Open Form 4 filing 0001567619-22-011707
2022-05-24 P, Open-market purchase Cantaloupe, Inc.CTLP 265,093, acquired Open Form 4 filing 0001567619-22-011707
2022-05-23 P, Open-market purchase Cantaloupe, Inc.CTLP 297,968, acquired Open Form 4 filing 0001567619-22-011707
2021-12-29 P, Open-market purchase Cantaloupe, Inc.CTLP 159,800, acquired Open Form 4 filing 0001567619-21-022629
2021-12-28 P, Open-market purchase Cantaloupe, Inc.CTLP 446,118, acquired Open Form 4 filing 0001567619-21-022629
2021-12-27 P, Open-market purchase Cantaloupe, Inc.CTLP 254,281, acquired Open Form 4 filing 0001567619-21-022629
2021-11-23 P, Open-market purchase Talkspace, Inc.TALK 2,080,000, acquired Open Form 4 filing 0001567619-21-021128
2021-08-16 P, Open-market purchase Talkspace, Inc.TALK 755,250, acquired Open Form 4 filing 0000899243-21-033194
2021-08-13 P, Open-market purchase Talkspace, Inc.TALK 240,580, acquired Open Form 4 filing 0000899243-21-033194
2021-08-12 P, Open-market purchase Talkspace, Inc.TALK 10,857, acquired Open Form 4 filing 0000899243-21-033194
2021-06-22 P, Open-market purchase Talkspace, Inc.TALK 50,000,000, acquired Open Form 4 filing 0000899243-21-025804
2020-06-26 P, Open-market purchase Cardtronics plcCATM 2 lines 3,837,070, acquired Open Form 4 filing 0000914121-20-002305
2020-06-25 P, Open-market purchase Cardtronics plcCATM 2 lines 2,410,003, acquired Open Form 4 filing 0000914121-20-002305
2020-06-23 P, Open-market purchase Cardtronics plcCATM 1,834,019, acquired Open Form 4 filing 0001567619-20-012517
2020-06-19 P, Open-market purchase Cardtronics plcCATM 2 lines 3,170,997, acquired Open Form 4 filing 0001567619-20-012517
2020-05-15 P, Open-market purchase Cardtronics plcCATM 739,096, acquired Open Form 4 filing 0001567619-20-010763
2019-10-25 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 981,302, disposed Open Form 4 filing 0001567619-19-020068
2019-10-24 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 93,412, disposed Open Form 4 filing 0001567619-19-020068
2019-10-23 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 12,516, disposed Open Form 4 filing 0001567619-19-019950
2019-10-22 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 411,618, disposed Open Form 4 filing 0001567619-19-019950
2019-10-21 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 240,791, disposed Open Form 4 filing 0001567619-19-019950
2019-10-18 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 100,174, disposed Open Form 4 filing 0001567619-19-019765
2019-10-17 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 866,196, disposed Open Form 4 filing 0001567619-19-019765
2019-10-16 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 6,375, disposed Open Form 4 filing 0001567619-19-019765
2019-10-16 P, Open-market purchase USA Technologies IncUSAT 1,198,494, acquired Open Form 4 filing 0001567619-19-019663
2019-10-15 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 244,836, disposed Open Form 4 filing 0001567619-19-019579
2019-10-14 P, Open-market purchase USA Technologies IncUSAT 536,024, acquired Open Form 4 filing 0001567619-19-019663
2019-10-11 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 984,419, disposed Open Form 4 filing 0001567619-19-019579
2019-10-10 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 471,002, disposed Open Form 4 filing 0001567619-19-019579
2019-10-08 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 93,520, disposed Open Form 4 filing 0001567619-19-019404
2019-10-07 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 294,600, disposed Open Form 4 filing 0001567619-19-019404
2019-09-26 P, Open-market purchase USA Technologies IncUSAT 2,943,325, acquired Open Form 4 filing 0001567619-19-018805
2019-09-25 P, Open-market purchase USA Technologies IncUSAT 5,213,914, acquired Open Form 4 filing 0001567619-19-018805
2019-09-24 P, Open-market purchase USA Technologies IncUSAT 88,000, acquired Open Form 4 filing 0001567619-19-018805
2019-09-23 P, Open-market purchase USA Technologies IncUSAT 638,672, acquired Open Form 4 filing 0001567619-19-018668
2019-09-17 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 6,000, disposed Open Form 4 filing 0001567619-19-018534
2019-09-12 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 12,014, disposed Open Form 4 filing 0001567619-19-018305
2019-09-11 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 66,785, disposed Open Form 4 filing 0001567619-19-018305
2019-08-01 P, Open-market purchase USA Technologies IncUSAT 6,931,746, acquired Open Form 4 filing 0001567619-19-015815
2019-05-10 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 5,614,000, disposed Open Form 4 filing 0001567619-19-010640
2019-05-09 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 3,431,973, disposed Open Form 4 filing 0001567619-19-010640
2019-03-12 P, Open-market purchase Corindus Vascular Robotics, Inc.CVRS 4,000,000, acquired Open Form 4 filing 0001567619-19-006905
2018-08-13 P, Open-market purchase Cardtronics plcCATM 1,640,901, acquired Open Form 4 filing 0001567619-18-001200
2018-08-10 P, Open-market purchase Cardtronics plcCATM 373,217, acquired Open Form 4 filing 0001567619-18-000430
2018-08-08 P, Open-market purchase Cardtronics plcCATM 382,031, acquired Open Form 4 filing 0001567619-18-000430
2018-05-03 P, Open-market purchase Cardtronics plcCATM 608,160, acquired Open Form 4 filing 0001140361-18-021786

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 5
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Braunstein Douglas L, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001495110

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.